Cytokinetics Inc (CYTK)

Total asset turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Revenue (ttm)	US$ in thousands	18,474	3,219	3,134	3,752	7,530	7,815	9,952	98,053	94,588	148,231	151,153	65,028	70,428	21,550	57,801	58,551	55,828	54,318	18,685	22,229
Total assets	US$ in thousands	1,401,670	1,436,060	1,523,790	808,082	824,316	740,614	779,899	889,815	1,014,780	1,075,960	771,717	856,253	841,319	827,539	564,302	577,062	533,803	474,112	232,495	256,582
Total asset turnover		0.01	0.00	0.00	0.00	0.01	0.01	0.01	0.11	0.09	0.14	0.20	0.08	0.08	0.03	0.10	0.10	0.10	0.11	0.08	0.09

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $18,474K ÷ $1,401,670K
= 0.01

The total asset turnover ratio for Cytokinetics Inc has experienced fluctuations over the years. It ranged from a low of 0.00 in March 2024, June 2024, and September 2024, to a high of 0.20 in June 2022. The ratio measures how efficiently the company is generating revenue from its total assets. A higher ratio indicates better efficiency in utilizing assets to generate sales.

The company saw a significant improvement in its total asset turnover from a low of 0.03 in September 2021 to 0.14 in September 2022, before dropping back down to 0.00 in the following periods. This could suggest changes in the company's operating efficiency and effectiveness in utilizing its assets to generate sales during these periods.

Overall, Cytokinetics Inc should focus on maintaining a consistent and efficient utilization of its assets to generate revenue in order to improve its financial performance and profitability in the long term.